We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+7.16%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$72.5B
AUM Growth
+$6.82B
Cap. Flow
+$3.05B
Cap. Flow %
4.21%
Top 10 Hldgs %
6.67%
Holding
4,357
New
897
Increased
1,473
Reduced
1,340
Closed
601

Sector Composition

Rank Sector Weight
1 Financials 14.49%
2 Technology 12.13%
3 Healthcare 11.89%
4 Consumer Discretionary 11.58%
5 Industrials 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CASC
3176
DELISTED
Cascadian Therapeutics, Inc.
CASC
$419K ﹤0.01%
113,300
+51,000
+82% +$209K
VEDL
3177
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$419K ﹤0.01%
+20,128
New +$394K
BXC icon
3178
BlueLinx
BXC
$653M
$417K ﹤0.01%
+42,732
New +$400K
HASI icon
3179
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.07B
$417K ﹤0.01%
17,320
-1,717
-9% -$41.1K
UONEK icon
3180
Urban One Class D
UONEK
$20.5M
$417K ﹤0.01%
23,834
-5,063
-18% -$85.1K
CCOI icon
3181
Cogent Communications
CCOI
$486M
$416K ﹤0.01%
+9,188
New +$438K
ABUS icon
3182
Arbutus Biopharma
ABUS
$1.03B
$414K ﹤0.01%
82,007
+61,961
+309% +$363K
TSC
3183
DELISTED
TriState Capital Holdings, Inc.
TSC
$414K ﹤0.01%
18,005
-1,533
-8% -$35.6K
AX icon
3184
Axos Financial
AX
$5.5B
$413K ﹤0.01%
13,809
-2,203
-14% -$59.9K
ASXC
3185
DELISTED
Asensus Surgical, Inc.
ASXC
$412K ﹤0.01%
16,426
-50,394
-75% -$1.55M
ARI
3186
Apollo Commercial Real Estate
ARI
$883M
$411K ﹤0.01%
+22,250
New +$410K
GMED icon
3187
CALL
Globus Medical
GMED
$11.3B
$411K ﹤0.01%
10,000
-264,400
-96% -$9.26M
TOVX icon
3188
Theriva Biologics
TOVX
$10.8M
$410K ﹤0.01%
92
-32
-26% -$200K
AMSC icon
3189
American Superconductor
AMSC
$1.4B
$407K ﹤0.01%
112,226
-83,290
-43% -$318K
FHI icon
3190
Federated Hermes
FHI
$4.83B
$407K ﹤0.01%
+11,278
New +$365K
TPST icon
3191
Tempest Therapeutics
TPST
$18.2M
$407K ﹤0.01%
99
-39
-28% -$164K
STBA icon
3192
S&T Bancorp
STBA
$1.77B
$405K ﹤0.01%
+10,165
New +$411K
AGTC
3193
DELISTED
Applied Genetic Technologies Corporation
AGTC
$405K ﹤0.01%
112,480
-104,301
-48% -$394K
FSCT
3194
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$405K ﹤0.01%
+12,685
New +$340K
ERN
3195
DELISTED
Erin Energy Corp
ERN
$404K ﹤0.01%
146,737
-164,005
-53% -$444K
DXLG icon
3196
Destination XL Group
DXLG
$35.2M
$399K ﹤0.01%
181,139
-357,133
-66% -$726K
FFC
3197
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$775M
$399K ﹤0.01%
+19,511
New +$408K
XRN
3198
Chiron Real Estate Inc
XRN
$494M
$399K ﹤0.01%
9,737
-1,051
-10% -$47K
SMRT
3199
DELISTED
Stein Mart Inc
SMRT
$399K ﹤0.01%
343,580
-504,440
-59% -$585K
AVK
3200
Advent Convertible and Income Fund
AVK
$559M
$390K ﹤0.01%
25,193
+8,022
+47% +$125K

Similar funds

Israel Englander's Q4 2017 Portfolio in Review

As of Q4 2017, Israel Englander held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Israel Englander deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.

  • Israel Englander's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
  • Israel Englander's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
  • Israel Englander fully exited Paychex in Q4 2017, selling an estimated $66.4M.
  • Israel Englander's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
  • Israel Englander opened 897 new positions and closed 601 in Q4 2017.
  • Israel Englander's portfolio value rose 10% quarter-over-quarter to $72.5B.

Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.